Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Nomogram of limited value in predicting non-SLN involvement after SN+ biopsy
February 10th, 2005
Data from a study by researchers in Hungary didn't validate a nomogram developed at the Memorial Sloan-Kettering Cancer Center for predicting non-sentinel lymph node (SLN) involvement after SLN positive biopsy. "After a positive sentinel lymph node biopsy, some patients may be considered to have a very low risk of non-SLN involvement and could be candidates for axillary sparing. The aim of this study was to validate the nomogram created at the Memorial Sloan-Kettering Cancer Center (MSKCC) for the prediction of non-SLN involvement in an independent set of 140 patients with both positive SLNs and axillary dissection," wrote L. Kocsis and colleagues, University of...
Source: Women's Health Weekly (2005-02-10)
|
